Ng Teng Fong General Hospital
16
3
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.3%
1 terminated/withdrawn out of 16 trials
87.5%
+1.0% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Early Oral Switch for Uncomplicated Gram-negative Bacteraemia
Role: collaborator
Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure
Role: collaborator
CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial
Role: collaborator
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
Role: collaborator
Impact of a Novel Heart Failure Medication Decision Aid
Role: collaborator
OSA and CV Outcomes in Patients With High Risk AF
Role: collaborator
A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling
Role: collaborator
Protocol for Multi-site Evaluation of New Community-based Frailty Programme
Role: collaborator
Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)
Role: collaborator
Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate
Role: collaborator
Pre- and Apnoeic Oxygenation for RSI in ED
Role: collaborator
Singapore Cardiac Longitudinal Outcomes Database
Role: collaborator
Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore
Role: collaborator
Gerontology Research Programme: The Singapore Longitudinal Ageing Studies (SLAS I & II)
Role: collaborator
Laryngeal Tube vs Laryngeal Mask Airway
Role: collaborator
Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)
Role: collaborator
All 16 trials loaded